Sign In
Buy ONTX
$1.00
+0 (+0%)
At Close: Jul 01, 2024
Onconova Therapeutics, Inc. (ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (
Dyadic International (DYAI) Receives a Buy from Noble Financial - Markets
08:06pm, Monday, 29'th Jun 2020
Noble Financial analyst Ahu Demir reiterated a Buy rating on Dyadic International (DYAI – Research Report) today and set a
Onconova Initiates Phase I/IIa Study on Lung Cancer Candidate
02:43pm, Tuesday, 23'rd Jun 2020
Onconova (ONTX) starts investigator-initiated phase I/IIa study of oral rigosertib plus Bristol-Myers Squibb's Opdivo in advanced metastatic KRAS-mutated lung adenocarcinoma.
Analysts Are Bullish on These Healthcare Stocks: Mersana Therapeutics (MRSN), Onconova Therapeutics (ONTX) - Markets
01:56pm, Tuesday, 23'rd Jun 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Mersana Therapeutics
Onconova Therapeutics Announces Participation in Noble Capital Markets Investor Webinar
12:00pm, Tuesday, 23'rd Jun 2020
NEWTOWN, Pa., June 23, 2020 -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to.
Onconova Therapeutics, Inc. (ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (
Noble Financial Thinks Onconova Therapeutics' Stock is Going to Recover - Markets
11:56am, Monday, 15'th Jun 2020
In a report released today, Ahu Demir from Noble Financial reiterated a Buy rating on Onconova Therapeutics (ONTX – Research
H.C. Wainwright Thinks Onconova Therapeutics' Stock is Going to Recover - Markets
10:18am, Monday, 15'th Jun 2020
In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Onconova Therapeutics (ONTX – Research
Onconova Therapeutics Announces Presentation at the 25th Congress of the European Hematology Association (EHA)
12:00pm, Friday, 12'th Jun 2020
Onconova Therapeutics, Inc. (ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (
Onconova Therapeutics Filing Shows Board Expects To Withdraw Reverse Stock Split Proposal For Annual Shareholder Meeting
09:42pm, Wednesday, 10'th Jun 2020Noble Financial Keeps a Buy Rating on Dyadic International (DYAI) - Markets
09:18pm, Wednesday, 10'th Jun 2020
In a report released today, Ahu Demir from Noble Financial reiterated a Buy rating on Dyadic International (DYAI – Research
Onconova Therapeutics Announces Presentation at BIO Digital 2020
12:00pm, Monday, 08'th Jun 2020
NEWTOWN, Pa., June 08, 2020 -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to.
3 "Strong Buy" Penny Stocks That Offer Massive Potential Gains
02:11pm, Thursday, 28'th May 2020
The stock market is heating up, and some Wall Street bulls are turning even more positive. Among those adapting an increasingly bullish approach is
3 “Strong Buy” Penny Stocks That Offer Massive Potential Gains
01:44pm, Thursday, 28'th May 2020
The stock market is heating up, and some Wall Street bulls are turning even more positive. Among those adapting an increasingly bullish approach is Stifel’s Head of Institutional Equity Strategy, Ba
Edited Transcript of ONTX earnings conference call or presentation 14-May-20 8:30pm GMT
03:33pm, Monday, 18'th May 2020
Q1 2020 Onconova Therapeutics Inc Earnings Call
